Adipose tissue and cancer: A high risk tandem;Tissu adipeux et cancer

Medecine/Sciences

Volumn 30, Issue 4, 2014, Pages 398-404

  Laurent, Victor ^a   Nieto, Laurence ^a   Valet, Philippe ^b   Muller, Catherine ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Université de Toulouse   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; HUMAN; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; TUMOR MICROENVIRONMENT;

ADIPOCYTES; ADIPOSE TISSUE; HUMANS; NEOPLASMS; RISK FACTORS; TUMOR MICROENVIRONMENT;

EID: 84900335738     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20143004013     Document Type: Article

References (39)

1. Allen M, Louise Jones J. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011; 223: 162-176.
2. Polanska UM, Orimo A. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol 2013; 228: 1651-1657.
3. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012; 33: 119-126.
4. Rajala MW, Scherer PE. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-3773.
5. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.
6. Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu Rev Nutr 2012; 32: 311-342.
7. Dirat B, Bochet L, Escourrou G, et al. Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocr Dev 2010; 19: 45-52.
8. Wang YY, Lehuede C, Laurent V, et al. Adipose tissue and breast epithelial cells: a dangerous dynamic duo in breast cancer. Cancer Lett 2012; 324: 142-151.
9. Smorlesi A, Frontini A, Giordano A, Cinti S., The adipose organ: white-brown adipocyte plasticity, metabolic inflammation. Obes Rev 2012; 13: suppl 2: 83-96.
10. Tsoli M, Moore M, Burg D, et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer Res 2012; 72: 4372-4382.
11. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature Rev Immunol 2011; 11: 85-97.
12. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009; 48: 275-297.
13. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005; 146: 1764-1771.
14. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139.
15. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443-477.
16. Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011; 71: 2455-2465.
17. Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physiol 2012; 302: C327-C359.
18. Elliott BE, Tam SP, Dexter D, Chen ZQ. Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int J Cancer 1992; 51: 416-424.
19. Manabe Y, Toda S, Miyazaki K, Sugihara H. Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol 2003; 201: 221-228.
20. Hefetz-Sela S, Scherer PE. Adipocytes: Impact on tumor growth and potential sites for therapeutic intervention. Pharmacol Ther 2013; 138: 197-210.
21. Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013; 1831: 1533-1541.
22. Andarawewa KL, Motrescu ER, Chenard MP, et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 2005; 65: 10862-10871.
23. Nieman KM, Kenny HA, Penicka CV, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011; 17: 1498-1503.
24. Finley DS, Calvert VS, Inokuchi J, et al. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol 2009; 182: 1621-1627.
25. Wagner M, Bjerkvig R, Wiig H, et al. Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis. Angiogenesis 2012; 15: 481-495.
26. Iyengar P, Espina V, Williams TW, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest 2005; 115: 1163-1176.
27. Park J, Scherer PE. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest 2012; 122: 4243-4256.
28. Motrescu ER, Blaise S, Etique N, et al. Matrix metalloproteinase-11/ stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene 2008; 27: 6347-6355.
29. Gazi E, Gardner P, Lockyer NP, et al. Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy. J Lipid Res 2007; 48: 1846-1856.
30. Bochet L, Meulle A, Imbert S, et al. Cancer-associated adipocytes promotes breast tumor radioresistance. Biochem Biophys Res Commun 2011; 411: 102-106.
31. Behan JW, Yun JP, Proektor MP, et al. Adipocytes impair leukemia treatment in mice. Cancer Res 2009; 69: 7867-7874.
32. Park J, Morley TS, Scherer PE. Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours. EMBO Mol Med 2013; 5: 935-948.
33. Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocrine Rev 2011; 32: 550-570.
34. Rose DP, Vona-Davis L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocrine Relat Cancer 2012; 19: R225-R241.
35. Divoux A, Clement K. Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obesity Rev 2011; 12: e494-e503.
36. Carrière A, Jeanson Y, Cousin B, et al. Le recrutement et l'activation d'adipocytes bruns et/ou BRITE: une perspective réelle pour le traitement des maladies métaboliques ? Med Sci (Paris) 2013; 29: 729-735.
37. Le Guellec S, Duprez-Paumier R, Lacroix-Triki M. Microenvironnement tumoral: la vision du pathologiste. Med Sci (Paris) 2014; 30: 372-377.
38. Provot S. Contrôle de la croissance et de la dissémination tumorales par le microenvironnement: certitudes et hypothèses émergentes. Med Sci (Paris) 2014; 30: 366-371.
39. Hasmim M, Messai Y, Zaeem M, Chouaib S. L'hypoxie tumorale: un déterminant clé de la réactivité stromale et de la réponse antitumorale. Med Sci (Paris) 2014; 30: 422-428.